Medicare Advantage Insurers Sue Government Over Star Ratings Impacting $4 Billion
A total of eleven Medicare Advantage insurers have initiated lawsuits against the federal government regarding the star ratings assigned to them for 2027, estimated to potentially cause approximately $4 billion in financial losses.
These legal actions, highlighted by Becker's Payer Issues, include claims from CVS Health, which alone predicts over $2 billion in impact. On November 6, Elevance Health, Banner Health, and Verda Healthcare joined this growing list of plaintiffs, following MediGold's suit on October 30. The crux of their argument lies in CMS's star rating system, which they claim uses metrics not formalized through the required notice and comment rulemaking process. This system's ratings significantly affect financial outcomes, as plans rated at 4 stars or higher receive bonus payments from Medicare, impacting the funds available for additional benefits.
The Contested Metrics
The impacted insurers, including CVS Health, Elevance, and Centene, contest the use of 28 metrics that they argue were unauthorized and therefore violate legal standards. This contention gained traction from a May ruling by U.S. District Judge Lisa Godbey Wood in a case involving Clover Health. The court found CMS at fault for employing measures without Congressional approval or necessary rulemaking. As a result, CMS revised Clover's main contract rating, illustrating the significant financial implications of such ratings.
With the CMS appealing the Clover decision, these current lawsuits demand that similar recalculations occur for other affected ratings. The insurers argue that the recalculated ratings should reflect a fair and legally grounded approach to ensure competitive equity and accurate compensation for Medicare Advantage plans.
Financial and Regulatory Implications
The stakes in these lawsuits are high. Medicare is anticipated to spend over $13 billion on quality bonuses in 2026, a significant increase from prior years. This expense underscores the critical nature of accurate and fair ratings. While the immediate impact on 2027 benefits remains unaffected due to set premiums, potential outcomes from these lawsuits could substantially influence 2028 benefits. Insurers could either offer enhanced benefits due to increased payments or face challenges in maintaining current benefits should the CMS's use of unauthorized metrics be upheld.
Recently, CMS has moved to simplify the star ratings system, with changes starting in 2029. However, immediate relief for insurers remains crucial as they await the appellate decision that could standardize future rating methodologies and compliance measures.
| Insurer | Estimated Financial Impact |
|---|---|
| CVS Health | Over $2 Billion |
| MediGold | Exceeding $62 Million |
The Path Forward for Insurers
As these lawsuits progress, the insurance industry awaits a ruling that could reshape how star ratings are determined, potentially altering competitive landscapes. Insurers seek adherence to legal standards to ensure the fairness of ratings that directly affect financial performance and consumer benefits. With the outcome still uncertain, insurance professionals and Medicare beneficiaries alike must remain vigilant, as changes may influence plan offerings and regulatory compliance in the years to come.
In light of potential legal and financial shifts, insurers are encouraged to keep abreast of ongoing litigation and CMS adjustments, ensuring they can adapt to emerging regulatory landscapes effectively. The evolving judicial interpretation of CMS's practices will likely set precedents influencing the Medicare Advantage domain long-term.